Safety evaluation of Veillonella atypica FB0054 with genotoxicity and subchronic toxicological studies
Veillonella atypica is a nonmotile, nonsporulating anaerobic bacteria commonly found in various human biofilms. V. atypica FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this...
Gespeichert in:
| Veröffentlicht in: | Journal of applied toxicology Jg. 43; H. 6; S. 808 - 827 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
England
Wiley Subscription Services, Inc
01.06.2023
|
| Schlagworte: | |
| ISSN: | 0260-437X, 1099-1263, 1099-1263 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Veillonella atypica is a nonmotile, nonsporulating anaerobic bacteria commonly found in various human biofilms. V. atypica FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this strain by rodents has been shown to increase their treadmill endurance, leading to the hypothesis that consumption of this species may improve athletic performance in humans as well. Further evaluation, in humans, of the usefulness of this strain should be preceded by safety studies. Therefore, the genotoxic and subchronic toxicological potential was evaluated as a contribution to this effort. Genotoxicity investigation was performed using the in vivo comet assay and in vivo mammalian micronucleus assay due to the anaerobic characteristic of the strain. A 90‐day, repeated‐dose oral toxicity study was performed in rats up to 2200 mg/kg bw/d to investigate general toxicity and identify any target organs. Mitsuoka buffer, a solution shown to preserve the viability of anaerobic bacteria, was used as the vehicle. All three studies revealed no toxicological effects from exposure to FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this strain by rodents has been shown to increase their treadmill endurance, leading to the hypothesis that consumption of this species may improve athletic performance in humans as well. Further evaluation, in humans, of the usefulness of this strain should be preceded by safety studies. Therefore, the genotoxic and subchronic toxicological potential was evaluated as a contribution to this effort. Genotoxicity investigation was performed using the in vivo comet assay and in vivo mammalian micronucleus assay due to the anaerobic characteristic of the strain. A 90‐day, repeated‐dose oral toxicity study was performed in rats up to 2200 mg/kg bw/d to investigate general toxicity and identify any target organs. Mitsuoka buffer, a solution shown to preserve the viability of anaerobic bacteria, was used as the vehicle. All three studies revealed no toxicological effects from exposure to FB0054 at the highest doses tested.
Veillonella atypica is an anaerobic bacteria found in human biofilms. A specific strain, V. atypica FB0054, was isolated from the stool of marathon runners. Its investigation as a probiotic should be preceded by a safety evaluation. The in vivo comet assay and in vivo mammalian micronucleus assay revealed a lack of genotoxicity. A no‐observed‐adverse‐effect‐level of 2200 mg/kg bw/d in rats, the highest dose tested, was determined based on the results of a repeated‐dose subchronic oral toxicity study. |
|---|---|
| AbstractList | Veillonella atypica is a nonmotile, nonsporulating anaerobic bacteria commonly found in various human biofilms. V. atypica FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this strain by rodents has been shown to increase their treadmill endurance, leading to the hypothesis that consumption of this species may improve athletic performance in humans as well. Further evaluation, in humans, of the usefulness of this strain should be preceded by safety studies. Therefore, the genotoxic and subchronic toxicological potential was evaluated as a contribution to this effort. Genotoxicity investigation was performed using the in vivo comet assay and in vivo mammalian micronucleus assay due to the anaerobic characteristic of the strain. A 90-day, repeated-dose oral toxicity study was performed in rats up to 2200 mg/kg bw/d to investigate general toxicity and identify any target organs. Mitsuoka buffer, a solution shown to preserve the viability of anaerobic bacteria, was used as the vehicle. All three studies revealed no toxicological effects from exposure to FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this strain by rodents has been shown to increase their treadmill endurance, leading to the hypothesis that consumption of this species may improve athletic performance in humans as well. Further evaluation, in humans, of the usefulness of this strain should be preceded by safety studies. Therefore, the genotoxic and subchronic toxicological potential was evaluated as a contribution to this effort. Genotoxicity investigation was performed using the in vivo comet assay and in vivo mammalian micronucleus assay due to the anaerobic characteristic of the strain. A 90-day, repeated-dose oral toxicity study was performed in rats up to 2200 mg/kg bw/d to investigate general toxicity and identify any target organs. Mitsuoka buffer, a solution shown to preserve the viability of anaerobic bacteria, was used as the vehicle. All three studies revealed no toxicological effects from exposure to FB0054 at the highest doses tested.Veillonella atypica is a nonmotile, nonsporulating anaerobic bacteria commonly found in various human biofilms. V. atypica FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this strain by rodents has been shown to increase their treadmill endurance, leading to the hypothesis that consumption of this species may improve athletic performance in humans as well. Further evaluation, in humans, of the usefulness of this strain should be preceded by safety studies. Therefore, the genotoxic and subchronic toxicological potential was evaluated as a contribution to this effort. Genotoxicity investigation was performed using the in vivo comet assay and in vivo mammalian micronucleus assay due to the anaerobic characteristic of the strain. A 90-day, repeated-dose oral toxicity study was performed in rats up to 2200 mg/kg bw/d to investigate general toxicity and identify any target organs. Mitsuoka buffer, a solution shown to preserve the viability of anaerobic bacteria, was used as the vehicle. All three studies revealed no toxicological effects from exposure to FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this strain by rodents has been shown to increase their treadmill endurance, leading to the hypothesis that consumption of this species may improve athletic performance in humans as well. Further evaluation, in humans, of the usefulness of this strain should be preceded by safety studies. Therefore, the genotoxic and subchronic toxicological potential was evaluated as a contribution to this effort. Genotoxicity investigation was performed using the in vivo comet assay and in vivo mammalian micronucleus assay due to the anaerobic characteristic of the strain. A 90-day, repeated-dose oral toxicity study was performed in rats up to 2200 mg/kg bw/d to investigate general toxicity and identify any target organs. Mitsuoka buffer, a solution shown to preserve the viability of anaerobic bacteria, was used as the vehicle. All three studies revealed no toxicological effects from exposure to FB0054 at the highest doses tested. Veillonella atypica is a nonmotile, nonsporulating anaerobic bacteria commonly found in various human biofilms. V. atypica FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this strain by rodents has been shown to increase their treadmill endurance, leading to the hypothesis that consumption of this species may improve athletic performance in humans as well. Further evaluation, in humans, of the usefulness of this strain should be preceded by safety studies. Therefore, the genotoxic and subchronic toxicological potential was evaluated as a contribution to this effort. Genotoxicity investigation was performed using the in vivo comet assay and in vivo mammalian micronucleus assay due to the anaerobic characteristic of the strain. A 90‐day, repeated‐dose oral toxicity study was performed in rats up to 2200 mg/kg bw/d to investigate general toxicity and identify any target organs. Mitsuoka buffer, a solution shown to preserve the viability of anaerobic bacteria, was used as the vehicle. All three studies revealed no toxicological effects from exposure to FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this strain by rodents has been shown to increase their treadmill endurance, leading to the hypothesis that consumption of this species may improve athletic performance in humans as well. Further evaluation, in humans, of the usefulness of this strain should be preceded by safety studies. Therefore, the genotoxic and subchronic toxicological potential was evaluated as a contribution to this effort. Genotoxicity investigation was performed using the in vivo comet assay and in vivo mammalian micronucleus assay due to the anaerobic characteristic of the strain. A 90‐day, repeated‐dose oral toxicity study was performed in rats up to 2200 mg/kg bw/d to investigate general toxicity and identify any target organs. Mitsuoka buffer, a solution shown to preserve the viability of anaerobic bacteria, was used as the vehicle. All three studies revealed no toxicological effects from exposure to FB0054 at the highest doses tested. Veillonella atypica is a nonmotile, nonsporulating anaerobic bacteria commonly found in various human biofilms. V. atypica FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this strain by rodents has been shown to increase their treadmill endurance, leading to the hypothesis that consumption of this species may improve athletic performance in humans as well. Further evaluation, in humans, of the usefulness of this strain should be preceded by safety studies. Therefore, the genotoxic and subchronic toxicological potential was evaluated as a contribution to this effort. Genotoxicity investigation was performed using the in vivo comet assay and in vivo mammalian micronucleus assay due to the anaerobic characteristic of the strain. A 90‐day, repeated‐dose oral toxicity study was performed in rats up to 2200 mg/kg bw/d to investigate general toxicity and identify any target organs. Mitsuoka buffer, a solution shown to preserve the viability of anaerobic bacteria, was used as the vehicle. All three studies revealed no toxicological effects from exposure to FB0054 was isolated from the gastrointestinal tract of marathon runners, who have increased amounts of this species after athletic events. Interestingly, the consumption of this strain by rodents has been shown to increase their treadmill endurance, leading to the hypothesis that consumption of this species may improve athletic performance in humans as well. Further evaluation, in humans, of the usefulness of this strain should be preceded by safety studies. Therefore, the genotoxic and subchronic toxicological potential was evaluated as a contribution to this effort. Genotoxicity investigation was performed using the in vivo comet assay and in vivo mammalian micronucleus assay due to the anaerobic characteristic of the strain. A 90‐day, repeated‐dose oral toxicity study was performed in rats up to 2200 mg/kg bw/d to investigate general toxicity and identify any target organs. Mitsuoka buffer, a solution shown to preserve the viability of anaerobic bacteria, was used as the vehicle. All three studies revealed no toxicological effects from exposure to FB0054 at the highest doses tested. Veillonella atypica is an anaerobic bacteria found in human biofilms. A specific strain, V. atypica FB0054, was isolated from the stool of marathon runners. Its investigation as a probiotic should be preceded by a safety evaluation. The in vivo comet assay and in vivo mammalian micronucleus assay revealed a lack of genotoxicity. A no‐observed‐adverse‐effect‐level of 2200 mg/kg bw/d in rats, the highest dose tested, was determined based on the results of a repeated‐dose subchronic oral toxicity study. |
| Author | Hirka, Gábor Murbach, Timothy S. Endres, John R. Béres, Erzsébet Glávits, Róbert Szakonyiné, Ilona Pasics Preece, Kayla E. Vértesi, Adél |
| Author_xml | – sequence: 1 givenname: Kayla E. orcidid: 0000-0002-0169-2112 surname: Preece fullname: Preece, Kayla E. email: kayla@aibmr.com organization: AIBMR Life Sciences, Inc – sequence: 2 givenname: Róbert surname: Glávits fullname: Glávits, Róbert organization: Toxi‐Coop Zrt – sequence: 3 givenname: Timothy S. orcidid: 0000-0002-7658-858X surname: Murbach fullname: Murbach, Timothy S. organization: AIBMR Life Sciences, Inc – sequence: 4 givenname: John R. surname: Endres fullname: Endres, John R. organization: AIBMR Life Sciences, Inc – sequence: 5 givenname: Gábor surname: Hirka fullname: Hirka, Gábor organization: Toxi‐Coop Zrt – sequence: 6 givenname: Adél surname: Vértesi fullname: Vértesi, Adél organization: Toxi‐Coop Zrt – sequence: 7 givenname: Erzsébet surname: Béres fullname: Béres, Erzsébet organization: Toxi‐Coop Zrt – sequence: 8 givenname: Ilona Pasics surname: Szakonyiné fullname: Szakonyiné, Ilona Pasics organization: Toxi‐Coop Zrt |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36547222$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kU9PGzEQxS0EgpAi8QmQpV64bLDH9nr3SFHpH0XiAEXcLMfrTRw563TtLeTb1wlQJFROI3l-b8bz3jHa70JnETqlZEIJgYulThPOodxDI0rquqBQsn00IlCSgjP5cISOY1wSkntQHaIjVgouAWCE2lvd2rTB9o_2g04udDi0-N467_MK7zXWabN2RuPrL4QIjh9dWuC57UIKT864LNVdg-MwM4s-dM7g3XvwYZ5FHsc0NM7GT-ig1T7ak5c6Rr-uv95dfS-mN99-XF1OC8N4XRYNY6KmgjdaktYAnZkSKmuEMYxYAZowKWVtKlNBDRSYoJZVwMumrcAIq9kYnT_PXffh92BjUisXzfaOzoYhKpBC5isYLzP6-R26DEPf5d8pqCiRTIKETJ29UMNsZRu17t1K9xv16uDbRtOHGHvb_kMoUdtwVA5HbcPJ6OQdmv3beZ567fz_BMWz4NF5u_lwsPp5ebfj_wKhl55Y |
| CitedBy_id | crossref_primary_10_1016_j_isci_2023_108643 crossref_primary_10_1186_s40001_024_01908_2 |
| Cites_doi | 10.1038/s41390-021-01678-1 10.1016/j.ijfoodmicro.2011.07.005 10.1038/s41591-019-0485-4 10.1093/mutage/get018 10.1002/ppul.25769 10.1002/9781118960608.gbm00710 10.3389/fcimb.2022.859967 10.1155/2021/9947213 10.1002/0471142735.ima03bs21 10.1186/s40168-017-0320-4 10.3389/fmicb.2020.01219 10.3389/fcimb.2021.609722 10.1007/s00394-020-02278-1 10.1093/oxfordjournals.bmb.a072564 10.1787/9789264264885-en 10.1007/s00296-021-05084-y 10.3390/ijms20102534 10.1016/0165-1110(83)90047-7 10.1016/j.anaerobe.2021.102491 10.1002/em.21881 10.1002/rcr2.493 10.1007/BF00401402 10.1016/j.yrtph.2015.07.003 10.1016/j.fufo.2021.100013 10.1007/s00394-022-02844-9 10.1093/mutage/gep060 10.1787/9789264078536-en 10.1002/(sici)1098-2280(2000)35:3<206::aid-em8>3.0.co;2-j 10.12938/bifidus.29.143 10.1136/gutjnl-2013-306541 |
| ContentType | Journal Article |
| Copyright | 2022 John Wiley & Sons Ltd. 2023 John Wiley & Sons, Ltd. |
| Copyright_xml | – notice: 2022 John Wiley & Sons Ltd. – notice: 2023 John Wiley & Sons, Ltd. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7ST 7TK 7U7 C1K K9. SOI 7X8 |
| DOI | 10.1002/jat.4426 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Environment Abstracts Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) Environment Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Toxicology Abstracts Neurosciences Abstracts Environment Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) CrossRef MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1099-1263 |
| EndPage | 827 |
| ExternalDocumentID | 36547222 10_1002_jat_4426 JAT4426 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: FitBiomics, Inc. |
| GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AAHQN AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEFU ABEML ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AI. AIAGR AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BY8 CS3 D-E D-F DCZOG DPXWK DR2 DRFUL DRSTM EBD EBS EDH EJD F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA GWYGA H.T H.X HF~ HGLYW HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6Q MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ UB1 V8K VH1 W8V W99 WBFHL WBKPD WH7 WIB WIH WIK WJL WOHZO WQJ WRC WUP WWP WXSBR WYISQ XG1 XPP XV2 YCJ YHZ ZXP ZZTAW ~02 ~IA ~KM ~WT AAMMB AAYXX AEFGJ AEYWJ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY AIQQE BANNL CITATION O8X CGR CUY CVF ECM EIF NPM 7ST 7TK 7U7 C1K K9. SOI 7X8 |
| ID | FETCH-LOGICAL-c3496-d3359154da70fc21bc628ec5cc30e52a037779c8c829212351e38246df82c5ea3 |
| IEDL.DBID | DRFUL |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000907878800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0260-437X 1099-1263 |
| IngestDate | Thu Sep 04 18:10:56 EDT 2025 Tue Oct 07 05:41:10 EDT 2025 Mon Jul 21 06:02:31 EDT 2025 Sat Nov 29 07:03:45 EST 2025 Tue Nov 18 21:35:48 EST 2025 Wed Jan 22 16:23:32 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | toxicity Wistar rats probiotic Veillonella atypica comet assay safety NOAEL |
| Language | English |
| License | 2022 John Wiley & Sons Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3496-d3359154da70fc21bc628ec5cc30e52a037779c8c829212351e38246df82c5ea3 |
| Notes | Funding information Adél Vértesi, Erzsébet Béres, and Ilona Pasics Szakonyiné are co‐senior authors. The authors disclose that financial support for the research described herein was provided by FitBiomics, Inc., New York, NY, USA. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-0169-2112 0000-0002-7658-858X |
| PMID | 36547222 |
| PQID | 2810737272 |
| PQPubID | 105373 |
| PageCount | 20 |
| ParticipantIDs | proquest_miscellaneous_2757054346 proquest_journals_2810737272 pubmed_primary_36547222 crossref_primary_10_1002_jat_4426 crossref_citationtrail_10_1002_jat_4426 wiley_primary_10_1002_jat_4426_JAT4426 |
| PublicationCentury | 2000 |
| PublicationDate | June 2023 2023-06-00 20230601 |
| PublicationDateYYYYMMDD | 2023-06-01 |
| PublicationDate_xml | – month: 06 year: 2023 text: June 2023 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England – name: Bognor Regis |
| PublicationSubtitle | JAT |
| PublicationTitle | Journal of applied toxicology |
| PublicationTitleAlternate | J Appl Toxicol |
| PublicationYear | 2023 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2017; 5 2019; 7 2021; 3 2013; 28 2012 2016b 2011 2016a 2015; 73 1998 2008 2022; 42 2020; 11 2014; 63 2021; 73 2021; 91 2011; 149 1968; 13 1983; 123 2010; 25 2021; 11 2001 2019; 20 2010; 29 2022; 61 2000; 35 2019; 25 2022; 12 2022; 57 2018 2017 2015 2014 1992; 48 2013 2021; 60 2014; 55 2021; 2021 e_1_2_8_28_1 e_1_2_8_29_1 Vidal J. (e_1_2_8_40_1) 2013 OECD (e_1_2_8_27_1) 2018 e_1_2_8_26_1 OECD (e_1_2_8_24_1) 2014 OECD (e_1_2_8_25_1) 2016 e_1_2_8_3_1 OECD (e_1_2_8_23_1) 2008 e_1_2_8_2_1 e_1_2_8_5_1 Johnson R. (e_1_2_8_16_1) 2013 National Research Council (e_1_2_8_21_1) 2011 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_9_1 e_1_2_8_8_1 e_1_2_8_20_1 e_1_2_8_22_1 e_1_2_8_41_1 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_39_1 e_1_2_8_19_1 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_15_1 e_1_2_8_38_1 e_1_2_8_37_1 e_1_2_8_32_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_30_1 |
| References_xml | – year: 2011 – volume: 29 start-page: 143 issue: 3 year: 2010 end-page: 148 article-title: Effect of enumeration method on cell counts in commercial powder products publication-title: Bioscience and Microflora – year: 2016b – start-page: 717 year: 2013 end-page: 830 – start-page: 209 year: 2013 end-page: 254 – volume: 3 year: 2021 article-title: Probiotics‐based foods and beverages as future foods and their overall safety and regulatory claims publication-title: Future Foods – year: 2001 – volume: 91 start-page: 1849 year: 2021 end-page: 1857 article-title: New and strains: Well tolerated and improve infant microbiota publication-title: Pediatric Research – volume: 13 start-page: 222 issue: 3 year: 1968 end-page: 257 article-title: Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse publication-title: Psychopharmacologia – year: 2001 article-title: Trypan blue exclusion test of cell viability publication-title: Current Protocols in Immunology – volume: 2021 year: 2021 article-title: bacteremia in alcoholic hepatitis publication-title: Case Reports in Hepatology – volume: 20 issue: 10 year: 2019 article-title: Health benefits of heat‐killed (tyndallized) probiotics: An overview publication-title: International Journal of Molecular Sciences – volume: 73 year: 2021 article-title: The first case of bacteremia in a patient with renal pelvic tumor publication-title: Anaerobe – volume: 73 start-page: 164 issue: 1 year: 2015 end-page: 171 article-title: Determining the safety of microbial cultures for consumption by humans and animals publication-title: Regulatory Toxicology and Pharmacology – year: 2018 – volume: 12 year: 2022 article-title: Efficacy of probiotics for irritable bowel syndrome: A systematic review and network meta‐analysis publication-title: Frontiers in Cellular and Infection Microbiology – year: 2014 – year: 1998 – year: 2012 – volume: 28 start-page: 427 issue: 4 year: 2013 end-page: 432 article-title: The comet assay, DNA damage, DNA repair and cytotoxicity: Hedgehogs are not always dead publication-title: Mutagenesis – year: 2016a – start-page: 1 year: 2015 end-page: 11 – volume: 5 start-page: 98 issue: 1 year: 2017 article-title: Community characteristics of the gut microbiomes of competitive cyclists publication-title: Microbiome – volume: 11 year: 2021 article-title: Probiotic gastrointestinal transit and colonization after oral administration: A long journey publication-title: Frontiers in Cellular and Infection Microbiology – volume: 42 start-page: 1207 issue: 7 year: 2022 end-page: 1211 article-title: Probiotic use in the prophylaxis of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: A retrospective cohort study publication-title: Rheumatology International – volume: 25 start-page: 187 issue: 2 year: 2010 end-page: 199 article-title: Combining the in vivo comet and micronucleus assays: A practical approach to genotoxicity testing and data interpretation publication-title: Mutagenesis – volume: 25 start-page: 1104 issue: 7 year: 2019 end-page: 1109 article-title: Meta‐omics analysis of elite athletes identifies a performance‐enhancing microbe that functions via lactate metabolism publication-title: Nature Medicine – year: 2008 – volume: 57 start-page: 508 issue: 2 year: 2022 end-page: 518 article-title: Airway microbiome dynamics and relationship to ventilator‐associated infection in intubated pediatric patients publication-title: Pediatric Pulmonology – volume: 48 start-page: 569 issue: 3 year: 1992 end-page: 591 article-title: Aerobic exercise, anaerobic exercise and the lactate threshold publication-title: British Medical Bulletin – volume: 60 start-page: 747 issue: 2 year: 2021 end-page: 758 article-title: Effects of probiotic supplementation on serum trimethylamine‐N‐oxide level and gut microbiota composition in young males: A double‐blinded randomized controlled trial publication-title: European Journal of Nutrition – volume: 7 issue: 9 year: 2019 article-title: A pulmonary infection by and in an immunocompetent patient with dental caries publication-title: Respirology Case Reports – volume: 123 start-page: 61 issue: 1 year: 1983 end-page: 118 article-title: The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene‐Tox Program publication-title: Mutation Research – volume: 149 start-page: 185 issue: 3 year: 2011 end-page: 193 article-title: Recommendations for the viability assessment of probiotics as concentrated cultures and in food matrices publication-title: International Journal of Food Microbiology – volume: 61 start-page: 2673 year: 2022 end-page: 2685 article-title: The effect of Unique IS‐2 supplementation on plasma amino acid levels and muscle strength in resistance trained males consuming whey protein: A double‐blind, placebo‐controlled study publication-title: European Journal of Nutrition – volume: 35 start-page: 206 issue: 3 year: 2000 end-page: 221 article-title: Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing publication-title: Environmental and Molecular Mutagenesis – volume: 63 start-page: 1913 issue: 12 year: 2014 end-page: 1920 article-title: Exercise and associated dietary extremes impact on gut microbial diversity publication-title: Gut – year: 2017 – volume: 11 year: 2020 article-title: Comparative genomics uncovers the genetic diversity and characters of and provides insights into its potential applications publication-title: Frontiers in Microbiology – volume: 55 start-page: 633 issue: 8 year: 2014 end-page: 642 article-title: Vehicle and positive control values from the in vivo rodent comet assay and biomonitoring studies using human lymphocytes: Historical database and influence of technical aspects publication-title: Environmental and Molecular Mutagenesis – ident: e_1_2_8_28_1 doi: 10.1038/s41390-021-01678-1 – ident: e_1_2_8_4_1 doi: 10.1016/j.ijfoodmicro.2011.07.005 – ident: e_1_2_8_33_1 doi: 10.1038/s41591-019-0485-4 – ident: e_1_2_8_19_1 doi: 10.1093/mutage/get018 – ident: e_1_2_8_37_1 doi: 10.1002/ppul.25769 – ident: e_1_2_8_3_1 doi: 10.1002/9781118960608.gbm00710 – ident: e_1_2_8_41_1 doi: 10.3389/fcimb.2022.859967 – ident: e_1_2_8_18_1 doi: 10.1155/2021/9947213 – volume-title: Test no. 474: Mammalian erythrocyte micronucleus test, OECD guidelines for the testing of chemicals year: 2016 ident: e_1_2_8_25_1 – ident: e_1_2_8_35_1 doi: 10.1002/0471142735.ima03bs21 – start-page: 717 volume-title: Toxicologic pathology. Nonclinical safety assessment year: 2013 ident: e_1_2_8_40_1 – ident: e_1_2_8_31_1 doi: 10.1186/s40168-017-0320-4 – ident: e_1_2_8_13_1 – start-page: 209 volume-title: Toxicologic pathology. Nonclinical safety assessment year: 2013 ident: e_1_2_8_16_1 – ident: e_1_2_8_10_1 doi: 10.3389/fmicb.2020.01219 – ident: e_1_2_8_11_1 doi: 10.3389/fcimb.2021.609722 – ident: e_1_2_8_5_1 doi: 10.1007/s00394-020-02278-1 – ident: e_1_2_8_34_1 doi: 10.1093/oxfordjournals.bmb.a072564 – ident: e_1_2_8_26_1 doi: 10.1787/9789264264885-en – ident: e_1_2_8_2_1 doi: 10.1007/s00296-021-05084-y – volume-title: Test no. 407: Repeated dose 28‐day oral toxicity study in rodents, OECD guidelines for the testing of chemicals, section 4 year: 2008 ident: e_1_2_8_23_1 – ident: e_1_2_8_32_1 doi: 10.3390/ijms20102534 – ident: e_1_2_8_12_1 doi: 10.1016/0165-1110(83)90047-7 – ident: e_1_2_8_15_1 doi: 10.1016/j.anaerobe.2021.102491 – ident: e_1_2_8_8_1 – ident: e_1_2_8_29_1 doi: 10.1002/em.21881 – ident: e_1_2_8_7_1 doi: 10.1002/rcr2.493 – ident: e_1_2_8_14_1 doi: 10.1007/BF00401402 – volume-title: OECD reports of the JaCVAM initiative international pre‐validation and validation studies of the in vivo rodent alkaline comet assay for detection of genotoxic carcinogens, series on testing and assessment, nos. 195 and 196 year: 2014 ident: e_1_2_8_24_1 – volume-title: Test no. 408: Repeated dose 90‐day oral toxicity study in rodents, OECD guidelines for the testing of chemicals, section 4 year: 2018 ident: e_1_2_8_27_1 – ident: e_1_2_8_30_1 doi: 10.1016/j.yrtph.2015.07.003 – ident: e_1_2_8_9_1 – ident: e_1_2_8_17_1 doi: 10.1016/j.fufo.2021.100013 – ident: e_1_2_8_36_1 doi: 10.1007/s00394-022-02844-9 – ident: e_1_2_8_39_1 doi: 10.1093/mutage/gep060 – ident: e_1_2_8_22_1 doi: 10.1787/9789264078536-en – ident: e_1_2_8_38_1 doi: 10.1002/(sici)1098-2280(2000)35:3<206::aid-em8>3.0.co;2-j – ident: e_1_2_8_20_1 doi: 10.12938/bifidus.29.143 – volume-title: Guide for the care and use of laboratory animals year: 2011 ident: e_1_2_8_21_1 – ident: e_1_2_8_6_1 doi: 10.1136/gutjnl-2013-306541 |
| SSID | ssj0009928 |
| Score | 2.3673215 |
| Snippet | Veillonella atypica is a nonmotile, nonsporulating anaerobic bacteria commonly found in various human biofilms. V. atypica FB0054 was isolated from the... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 808 |
| SubjectTerms | Anaerobic bacteria Animals Athletic performance Bacteria Bioassays Biocompatibility Biofilms Buffers Comet Assay Consumption DNA Damage Endurance Gastrointestinal system Gastrointestinal tract Genotoxicity Humans Hypotheses In vivo methods and tests Investigations Mammals Marathons Micronucleus Tests Mutagenicity Tests NOAEL Organs probiotic Rats Rodents Safety Target recognition Toxicity Toxicity testing Toxicity Tests, Subchronic Treadmills Veillonella Veillonella atypica Wistar rats |
| Title | Safety evaluation of Veillonella atypica FB0054 with genotoxicity and subchronic toxicological studies |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjat.4426 https://www.ncbi.nlm.nih.gov/pubmed/36547222 https://www.proquest.com/docview/2810737272 https://www.proquest.com/docview/2757054346 |
| Volume | 43 |
| WOSCitedRecordID | wos000907878800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Journals customDbUrl: eissn: 1099-1263 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009928 issn: 0260-437X databaseCode: DRFUL dateStart: 19960101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEB-8Ox8E8eP8Wj2PCLK-XL1s0mzSR78WH-RY9E72raSTBFZk97h2xf3vzTTtlkMFwadCO01CMpOZTGZ-A_BSTSqvqonNCqttljuHWdRyPENnvdaVC1KHttiEPjszi0Ux76IqKRcm4UPsHG4kGe1-TQJuq_p0AA39ZpvXedQve3BAOVXx4HXw_vPs4tMAuVu0lVUJNCvLpV700LNcnPb_XldGv1mY1w3WVuPM7v7PWO_Bnc7OZG8SY9yHG351CON5AqrenrDzIe-qPmFjNh8grLeHcDt581hKUnoA4YsNvtmyARucrQP76pd0a0_xU8w228u43mz2lswzRu5dRvivzfrnEqOlz-zKsXpTYQLjZe37fuNldYpmfAgXsw_n7z5mXYWGDAloPnNSqiIaYc5qHlBMKpwK41EhSu6VsFxqrQs0aERBOlJNvDQin7pgBCpv5SPYX8VxPgFmMMicI4aC-zxUvtJaWe-mmk9tkWs7glf9UpXYwZdTFY3vZQJeFmWc5JImeQQvdpSXCbLjDzRH_WqXndDWpTDxLCzpZjo2sfscxY3uUOzKrzeRRivNKR03NvE4ccmuE0mFnKO9NYJxywx_7b2MWy89n_4r4TO4RWXuU4jaEew3Vxv_HG7ij2ZZXx3Dnl6Y4479fwGNkAkR |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-NDgmkicH4KgwwEiovC3PtOHbE0_iohihVBd3Ut8hxbKkItdOSTvS_xxcnjSZAQuIpUnKxLdvn-_ns-x3AKzHMrciHOkq11FFcFCbyVo5GptBWyrxwXLo62YScTNR8nk534G0bCxP4IbYON9SMer1GBUeH9HHHGvpdV29ib2BuwG6ccKl6sPvh6-hs3HHupnVqVWTNimIu5y33LGXH7b_XrdFvEPM6Yq1Nzmj_vxp7F-40SJOchKlxD3bs8gAG00BVvTkisy7yqjwiAzLtSKw3B7AX_HkkhCndB_dNO1ttSMcOTlaOnNsFntvjDSqiq82FH3EyeocAjaCDlyADbLX6uTAe6xO9LEi5zk2g4yX1-3bpJWW4z_gAzkYfZ-9PoyZHQ2SQaj4qOBeph2GFltQZNsxNwpQ1whhOrWCacillapRRLEUrKYaWKxYnhVPMCKv5Q-gtfTsfA1HG8Zga41JqY5fbXEqhbZFImug0lroPr9uxykxDYI55NH5kgXqZZb6TM-zkPrzcSl4E0o4_yBy2w501altmTPndMMezaV_E9rNXODxF0Uu7WnsZKSTFgFxfxKMwTbaVcEzl7BFXHwb1bPhr7ZlffPH55F8FX8Ct09mXcTb-NPn8FG5j0vtwYe0QetXl2j6Dm-aqWpSXzxst-AUi4gwZ |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3di9QwEMCHc09EED_Or9VTI8j6cvWyTbJp8Ek9i-KxLHon-1bSSQIrsrtcu-L-9yZNu-VQQfCp0E7TkGQy0yTzG4AXYlxaUY51orTUCTcGE2_laIJGWylL45h0TbIJOZ1m87ma7cHrLhYm8iF2C25BM5r5Oii4XRt33FNDv-n6FfcG5grsc6EEH8D-yef8_LRn7qomtWqgZiWcyXnHnqXpcffuZWv0m4t52WNtTE5-678qextutp4meROHxh3Ys8sDGM0iqnp7RM76yKvqiIzIrIdYbw_gRlzPIzFM6S64L9rZekt6OjhZOfLVLsK-fThBRXS9XfseJ_nb4KCRsMBLAgG2Xv1coPf1iV4aUm1KjDhe0tzvpl5SxfOM9-A8f3_27kPS5mhIMKDmE8OYUN4NM1pSh-m4xEmaWRSIjFqRasqklAozzFIVrKQYW5alfGJclqKwmt2HwdLX8yGQDB3jFNEparkrbSml0NZMJJ1oxaUewsuurwpsAeYhj8b3IqKX08I3chEaeQjPd5LrCO34g8xh191Fq7ZVkWb-b5iFvWlfxO6xV7iwi6KXdrXxMlJIGgJyfREP4jDZfYSFVM7e4xrCqBkNf_164SffcH30r4LP4NrsJC9OP04_PYbrIed9PK92CIP6YmOfwFX8US-qi6etEvwCnVILlA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+evaluation+of+Veillonella+atypica+FB0054+with+genotoxicity+and+subchronic+toxicological+studies&rft.jtitle=Journal+of+applied+toxicology&rft.au=Preece%2C+Kayla+E&rft.au=Gl%C3%A1vits%2C+R%C3%B3bert&rft.au=Murbach%2C+Timothy+S&rft.au=Endres%2C+John+R&rft.date=2023-06-01&rft.issn=1099-1263&rft.eissn=1099-1263&rft.volume=43&rft.issue=6&rft.spage=808&rft_id=info:doi/10.1002%2Fjat.4426&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0260-437X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0260-437X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0260-437X&client=summon |